1\. To develop a multiactivity training programme. 2. To explore the effect of this programme on sarcopenia, sarcopenic obesity, cognitive impairment and Parkinson's disease. 3. To compare the effects of the experimental and control treatments on the muscle strength, body composition, physical function performance and quality of life of the elderly.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Enrollment
207
protein supplementation for 16 weeks
muscle strength training for 16 weeks
no intervention
Daycare center at Central Taiwan University of Science and Technology
Taichung, Taiwan
Chang in muscle strength from baseline to 16 weeks
pinch, grip and quadriceps strength. A Higher score means a better outcome.
Time frame: Baseline and 16 weeks
Chang in weight of muscle and fat from baseline to 16 weeks
muscle mass(kg), fat mass (kg)
Time frame: Baseline and 16 weeks
Chang in Activities of Daily Living from baseline to 16 weeks
This is a scale of physical function. The range for total score is 0-100. A Higher score means a worse outcome.
Time frame: Baseline and 16 weeks
Chang in Instrumental activities of daily living from baseline to 16 weeks
This is a scale of physical function. The range for total score is 0-24. A Higher score means a better outcome.
Time frame: Baseline and 16 weeks
Chang in Clinical Dementia Rating from baseline to 16 weeks
Mental Function Assessment. The range is 0-3. A Higher score means a worse outcome.
Time frame: Baseline and 16 weeks
Chang in Cornell Scale for Depression in Dementia from baseline to 16 weeks
Mental Function Assessment. The range for total score is 0-38. A Higher score means a worse outcome.
Time frame: Baseline and 16 weeks
Chang in Cohen-Mansfield Agitation Inventory from baseline to 16 weeks
This is a scale of behavior measurement. The range for total is 29-203. A higher score means a worse outcome.
Time frame: Baseline and 16 weeks
Chang in EQ5D from baseline to 16 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
This is a scale of quality of life. The range for total is 0-20. A higher score means a worse outcome.
Time frame: Baseline and 16 weeks
Chang in QUALIDEM from baseline to 16 weeks
The scale is a dementia-specific Qol instrument. The range for total score is 0-120. A higher score means a better outcome.
Time frame: Baseline and 16 weeks
Demographic attributes
Gender, education, age, married status, religion, medication, diseases, work and height.
Time frame: Baseline
Chang in PERSONAL WELLBEING INDEX from baseline to 16 weeks
The range for total is 0-80. A higher score means a better outcome.
Time frame: Baseline and 16 weeks
Chang in PERSONAL WELLBEING INDEX intellectual disability from baseline to 16 weeks
The range for total is 0-70. A higher score means a better outcome.
Time frame: Baseline and 16 weeks.
Chang in World Health Organization Quality of Life Instruments (WHOQOL-BREF) from baseline to 16 weeks
This is a scale of quality of life. The range for total is 26-130. A higher score means a better outcome.
Time frame: Baseline and 16 weeks.
Chang in Four-Meter Gait Speed from baseline to 16 weeks
Measured with seconds. A higher score means a worse outcome.
Time frame: Baseline and 16 weeks.